Differences in men and women in coronary artery disease, systemic hypertension and their treatment

Area of Science:

• Cardiovascular Medicine
• Hypertension Research
• Sex-Based Medicine

Background:

• Coronary artery disease (CAD) and hypertension disproportionately affect women, yet treatment disparities persist compared to men.
• Hypertension poses a higher attributable risk for cardiovascular complications in women, but specific treatment guidelines remain scarce.
• Existing research indicates potential harm to white women from standard antihypertensive therapies, highlighting a need for differentiated treatment strategies.

Discussion:

• The reasons behind differential treatment of women with CAD are unclear and may stem from misconceptions.
• The higher cardiovascular risk associated with hypertension in women is not adequately addressed by current medical information.
• There is a critical need to investigate and establish sex-specific protocols for managing hypertension in women.

Key Insights:

• Women with cardiovascular conditions, particularly hypertension, are treated differently than men.
• Antihypertensive treatments may pose risks to certain demographics of women, such as white women.
• A lack of consensus exists regarding the necessity of sex-specific antihypertensive treatments.

Outlook:

• Future research should focus on developing and validating sex-specific hypertension treatment guidelines.
• Clinical practice must evolve to incorporate evidence-based, gender-tailored approaches for cardiovascular disease management.
• Further investigation is required to understand and mitigate potential harm from current antihypertensive regimens in women.